Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
- Author(s):
- Pollack, C.V.; Reilly, P.A.; Ryn, J. van; Eikelboom, J.W.; Glund, S.; Bernstein, R.A.; Dubiel, R.; Huisman, M.V. (0000-0003-1423-5348); Hylek, E.M.; Kam, C.W.; Kamphuisen, P.W.; Kreuzer, J.; Levy, J.H.; Royle, G.; Sellke, F.W.; Stangier, J.; Steiner, T.; Verhamme, P.; Wang, B.S.; Young, L.; Weitz, J.I.
- Published
- 2017
- Publication type
- Article / Letter to editor
- Date issued
- 2017-08-03
- Language
- English
- Is part of
- New England Journal of Medicine (2017), Vol. 377, no. 5, p. 431-441
- hdl
- 1887/115771
- doi
- 10.1056/NEJMoa1707278